Christensen SB - Search Results

1

Preparation of Enzyme-Activated Thapsigargin Prodrugs by Solid-Phase Synthesis.

Zimmermann T, Christensen SB, Franzyk H. Zimmermann T, et al. Among authors: christensen sb. Molecules. 2018 Jun 15;23(6):1463. doi: 10.3390/molecules23061463. Molecules. 2018. PMID: 29914143 Free PMC article.

2

Targeting Toxins toward Tumors.

Franzyk H, Christensen SB. Franzyk H, et al. Among authors: christensen sb. Molecules. 2021 Feb 27;26(5):1292. doi: 10.3390/molecules26051292. Molecules. 2021. PMID: 33673582 Free PMC article. Review.

3

Iminolactones as tools for inversion of the absolute configuration of α-amino acids and as inhibitors of cancer cell proliferation.

Jensen CM, Chow HQ, Chen M, Zhai L, Frydenvang K, Liu H, Franzyk H, Christensen SB. Jensen CM, et al. Among authors: christensen sb. Eur J Med Chem. 2016 May 23;114:118-33. doi: 10.1016/j.ejmech.2016.02.037. Epub 2016 Feb 23. Eur J Med Chem. 2016. PMID: 26974380

4

Phorbol Rearrangements.

Zimmermann T, Franzyk H, Christensen SB. Zimmermann T, et al. Among authors: christensen sb. J Nat Prod. 2018 Sep 28;81(9):2134-2137. doi: 10.1021/acs.jnatprod.8b00607. Epub 2018 Sep 14. J Nat Prod. 2018. PMID: 30216064

5

Missing Selectivity of Targeted 4β-Phorbol Prodrugs Expected to be Potential Chemotherapeutics.

Tarvainen I, Zimmermann T, Heinonen P, Jäntti MH, Yli-Kauhaluoma J, Talman V, Franzyk H, Tuominen RK, Christensen SB. Tarvainen I, et al. Among authors: christensen sb. ACS Med Chem Lett. 2019 Dec 23;11(5):671-677. doi: 10.1021/acsmedchemlett.9b00554. eCollection 2020 May 14. ACS Med Chem Lett. 2019. PMID: 32435369 Free PMC article.

6

Large Scale Conversion of Trilobolide into the Payload of Mipsagargin: 8-O-(12-Aminododecanoyl)-8-O-Debutanoylthapsigargin.

Zimmermann T, Drašar P, Rimpelová S, Christensen SB, Khripach VA, Jurášek M. Zimmermann T, et al. Among authors: christensen sb. Biomolecules. 2020 Dec 5;10(12):1640. doi: 10.3390/biom10121640. Biomolecules. 2020. PMID: 33291419 Free PMC article.

7

Mipsagargin: The Beginning-Not the End-of Thapsigargin Prodrug-Based Cancer Therapeutics.

Isaacs JT, Brennen WN, Christensen SB, Denmeade SR. Isaacs JT, et al. Among authors: christensen sb. Molecules. 2021 Dec 9;26(24):7469. doi: 10.3390/molecules26247469. Molecules. 2021. PMID: 34946547 Free PMC article. Review.

8

Targeting thapsigargin towards tumors.

Doan NT, Paulsen ES, Sehgal P, Møller JV, Nissen P, Denmeade SR, Isaacs JT, Dionne CA, Christensen SB. Doan NT, et al. Among authors: christensen sb. Steroids. 2015 May;97:2-7. doi: 10.1016/j.steroids.2014.07.009. Epub 2014 Jul 24. Steroids. 2015. PMID: 25065587 Free PMC article. Review.

9

Thapsigargin, Origin, Chemistry, Structure-Activity Relationships and Prodrug Development.

Quynh Doan NT, Christensen SB. Quynh Doan NT, et al. Among authors: christensen sb. Curr Pharm Des. 2015;21(38):5501-17. doi: 10.2174/1381612821666151002112824. Curr Pharm Des. 2015. PMID: 26429715 Review.

10

Drugs That Changed Society: Microtubule-Targeting Agents Belonging to Taxanoids, Macrolides and Non-Ribosomal Peptides.

Christensen SB. Christensen SB. Molecules. 2022 Sep 1;27(17):5648. doi: 10.3390/molecules27175648. Molecules. 2022. PMID: 36080414 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

249 results

Search Page